|
TVMR With the INNOVALVE System Trial - Early Feasibility Study
RECRUITINGN/ASponsored by Edwards Lifesciences
Actively Recruiting
PhaseN/A
SponsorEdwards Lifesciences
Started2022-09-01
Est. completion2026-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations20 sites
View on ClinicalTrials.gov →
NCT04919980
Summary
Study to evaluate the safety and performance of the INNOVALVE system
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Clinically significant, symptomatic mitral regurgitation * High risk for open-heart surgery * Meets anatomical criteria Exclusion Criteria: * Unsuitable anatomy * Patient is inoperable * EF\<25%
Conditions2
Heart DiseaseMitral Valve Regurgitation (Degenerative or Functional)
Locations20 sites
Piedmont Heart Institute
Find trials near these locations
Heart Disease trials in Los AngelesHeart Disease trials in AtlantaHeart Disease trials in ChicagoHeart Disease trials in Kansas CityHeart Disease trials in New YorkHeart Disease trials in ClevelandHeart Disease trials in ColumbusHeart Disease trials in PortlandHeart Disease trials in PhiladelphiaHeart Disease trials in NashvilleHeart Disease trials in SeattleAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in MinnesotaAll trials in MissouriAll trials in New YorkAll trials in OhioAll trials in OregonAll trials in PennsylvaniaAll trials in TennesseeAll trials in Washington
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorEdwards Lifesciences
Started2022-09-01
Est. completion2026-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations20 sites
View on ClinicalTrials.gov →
NCT04919980